DUBLIN–(BUSINESS WIRE)–The “Israel: CBD and Cannabis Regulation” report has been added to ResearchAndMarkets.com’s offering.
This report provides a detailed overview of Israel’s regulatory framework for CBD, hemp, and cannabis.
The constant government changes that have taken place over the last two years, along with the general composition of the Knesset (Israeli’s parliament) with multiple parties with different ideologies, make predicting the future of Israel’s CBD sector difficult.
CBD is no longer considered a scheduled substance and will be allowed in foods and cosmetics once the Ministry of Health permits it.
Key Topics Covered:
1 Executive Summary
3 Hemp Plant
4 Extracts As Finished Product
5 Finished Products Containing CBD And Extracts
6 Import/ Export
7 Medical Cannabis
8 Recreational Cannabis
9 Relevant Laws
10 Relevant Bodies
For more information about this report visit https://www.researchandmarkets.com/r/b3w3cn.
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900